Holen Sie sich die Stockscreener-App
65.66
1.02%
0.66
Biomarin Pharmaceutical Inc Aktie (BMRN) Neueste Nachrichten
Stifel Financial Corp Decreases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.20 Average Price Target from Brokerages - MarketBeat
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock? - Yahoo Finance
BioMarin's SWOT analysis: rare disease leader's stock faces growth hurdles By Investing.com - Investing.com Canada
BioMarin's SWOT analysis: rare disease leader's stock faces growth hurdles - Investing.com
National Bank of Canada FI Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Tidal Investments LLC Raises Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace
Geode Capital Management LLC Acquires 60,692 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Teachers Retirement System of The State of Kentucky Sells 134,167 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Virtu Financial LLC Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time - The Eastern Progress Online
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET - The Eastern Progress Online
The Latest Analyst Ratings For Biomarin Pharmaceutical - Benzinga
BioMarin's SWOT analysis: rare disease stock faces growth and competition - Investing.com
Major pharma-company invests €60m in new plant in vote of confidence for Cork - MSN
BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Y Intercept Hong Kong Ltd Buys New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Neo Ivy Capital Management - MarketBeat
Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Yahoo Finance
Fmr LLC Buys 36,877 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Pharma giant BioMarin announces €60m investment in Cork facility - MSN
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Canada Finance
Nomura Asset Management Co. Ltd. Acquires 110,683 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Two Sigma Advisers LP Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin to add €60M lab to Irish manufacturing site in push to grow production capacity - FiercePharma
BioMarin's Rare Disease Portfolio and Strong Voxzogo Launch Support Narrow Moat Rating - Morningstar
BioMarin Pharmaceutical Inc announce €60m investment in Cork plant - Business Plus
BioMarin announces €60m Cork expansion - SiliconRepublic.com
BioMarin announces significant investment and expansion of Cork facility - Cork's 96FM
Worldquant Millennium Advisors LLC Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Centiva Capital LP Buys Shares of 7,511 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Jacobs Levy Equity Management Inc. Invests $3.66 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin to Participate in Three Upcoming Investor Conferences - The Eastern Progress Online
Interesting BMRN Put And Call Options For December 20th - Nasdaq
BioMarin Pharmaceutical (NASDAQ:BMRN) investors are sitting on a loss of 29% if they invested a year ago - Simply Wall St
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Motley Fool Wealth Management LLC - MarketBeat
Holocene Advisors LP Has $39.61 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
The Manufacturers Life Insurance Company Decreases Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Edgestream Partners L.P. Invests $2.01 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stake Lifted by Rockefeller Capital Management L.P. - MarketBeat
BNP Paribas Financial Markets Lowers Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
PDT Partners LLC Invests $2.32 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Erste Asset Management GmbH Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Bellevue Group AG Acquires 278,744 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Vestal Point Capital LP Buys New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Bridgewater Associates LP - MarketBeat
Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report? - Yahoo Finance
FORA Capital LLC Acquires 16,926 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Dynamic Technology Lab Private Ltd Makes New $1.01 Million Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):